US-Drohnenfirma: Aktienkurs steigt um 1000 Prozent
Der Aktienkurs der Drohnenfirma Swarmer ist innerhalb von zwei Tagen um 1000 Prozent gestiegen. Es ist der stärkste Wertzuwachs einer US-Aktie seit einem Jahr.
https://ww…
National Academies of Sciences says no to demands it remove climate info
State attorneys general won’t get climate chapter removed from a legal manual
https://arstechnica.com/science/2026/03/national-academies-of-sciences-r…
Ambitious climate action could save 1.32 million lives a year by 2040 #climate
academia_edu: Academica.edu (2011)
Snapshot of the follower relationships among users of academia.edu, a platform for academics to share research papers, scraped in 2011. Nodes are users and a directed edge (i,j) denotes that user i follows j.
This network has 200169 nodes and 1398063 edges.
Tags: Social, Online, Unweighted
https://
Austin-based Circuit, which is building an AI platform for manufacturing and service enterprises, raised $30M from a group of angel investors (Karoline Leonard/Austin American-Statesman)
https://www.statesman.com/business/technol
"I love acting because it's a bit of an escape. It gives you the ability to reinvent yourself. They say that acting is the shy man's revenge."
—Hayden Christensen
#acting #coaching #inspiration
“Universities have to be at the forefront of countering this tidal wave of misleadingness. Universities are where truth and knowledge are discussed, debated, contested, and as a result discovered. It is why the first assault of autocrats across the world is always on education.”
[Documenting >1,000 attacks to date on science, education & true information:
"I think my high-school acting career lasted a day."
—Dennis Farina
#acting #coaching #inspiration
Vom AI-Hype zur AI-Angst: Warum Tech-Aktien 2026 so stark verlieren
Backlash: Big-Tech-Aktien notieren seit Jahresbeginn im Minus. Die Wall Street ist über das Disruptionspotenzial besorgt.
https://www.…
A look at China's push to become a world leader in brain-computer interfaces, as Shanghai-based startup NeuroXess moves to human trials with Beijing's backing (Eleanor Olcott/Financial Times)
https://giftarticle.ft.com/giftarticle/actions/re…